Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS

BACKGROUND: Brain structural alterations and their clinical significance of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) have not been determined. METHODS: We recruited 35 MOGAD, 38 aquaporin 4 antibody positive neuromyelitis optica spectrum diseases (AQP4+ NMOSD), 37 multiple sclero...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurol Neurosurg Psychiatry
Main Authors: Duan, Yunyun, Zhuo, Zhizheng, Li, Haiqing, Tian, De-Cai, Li, Yuxin, Yang, Liqin, Gao, Chenyang, Zhang, Tian, Zhang, Xinghu, Shi, Fu-Dong, Barkhof, Frederik, Liu, Yaou
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2021
Assuntos:
Multiple Sclerosis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8223649/
https://ncbi.nlm.nih.gov/pubmed/33687975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2020-324826
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares